Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,490
0.00 (0.00%)
At close: Sep 5, 2025

Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 160.15 billion. The enterprise value is 115.08 billion.

Market Cap160.15B
Enterprise Value 115.08B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date Nov 13, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

Whan In Pharm has 15.27 million shares outstanding.

Current Share Class 15.27M
Shares Outstanding 15.27M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 28.36%
Owned by Institutions (%) 15.08%
Float 10.94M

Valuation Ratios

The trailing PE ratio is 9.76 and the forward PE ratio is 6.66.

PE Ratio 9.76
Forward PE 6.66
PS Ratio 0.62
PB Ratio 0.42
P/TBV Ratio 0.43
P/FCF Ratio 19.08
P/OCF Ratio 10.86
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.74, with an EV/FCF ratio of 13.71.

EV / Earnings 7.01
EV / Sales 0.44
EV / EBITDA 4.74
EV / EBIT 7.86
EV / FCF 13.71

Financial Position

The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.00.

Current Ratio 4.91
Quick Ratio 2.80
Debt / Equity 0.00
Debt / EBITDA 0.04
Debt / FCF 0.10
Interest Coverage 553.75

Financial Efficiency

Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 2.36%.

Return on Equity (ROE) 4.38%
Return on Assets (ROA) 2.08%
Return on Invested Capital (ROIC) 2.36%
Return on Capital Employed (ROCE) 3.66%
Revenue Per Employee 427.61M
Profits Per Employee 27.12M
Employee Count 605
Asset Turnover 0.61
Inventory Turnover 2.24

Taxes

In the past 12 months, Whan In Pharm has paid 849.69 million in taxes.

Income Tax 849.69M
Effective Tax Rate 4.92%

Stock Price Statistics

The stock price has decreased by -20.65% in the last 52 weeks. The beta is 0.28, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y) 0.28
52-Week Price Change -20.65%
50-Day Moving Average 11,873.60
200-Day Moving Average 11,758.65
Relative Strength Index (RSI) 27.33
Average Volume (20 Days) 47,043

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 258.70 billion and earned 16.41 billion in profits. Earnings per share was 1,074.45.

Revenue258.70B
Gross Profit 85.60B
Operating Income 14.18B
Pretax Income 17.26B
Net Income 16.41B
EBITDA 23.81B
EBIT 14.18B
Earnings Per Share (EPS) 1,074.45
Full Income Statement

Balance Sheet

The company has 45.95 billion in cash and 872.93 million in debt, giving a net cash position of 45.07 billion or 2,952.40 per share.

Cash & Cash Equivalents 45.95B
Total Debt 872.93M
Net Cash 45.07B
Net Cash Per Share 2,952.40
Equity (Book Value) 380.48B
Book Value Per Share 24,921.78
Working Capital 163.36B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.74 billion and capital expenditures -6.35 billion, giving a free cash flow of 8.39 billion.

Operating Cash Flow 14.74B
Capital Expenditures -6.35B
Free Cash Flow 8.39B
FCF Per Share 549.87
Full Cash Flow Statement

Margins

Gross margin is 33.09%, with operating and profit margins of 5.48% and 6.34%.

Gross Margin 33.09%
Operating Margin 5.48%
Pretax Margin 6.67%
Profit Margin 6.34%
EBITDA Margin 9.20%
EBIT Margin 5.48%
FCF Margin 3.25%

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.86%.

Dividend Per Share 300.00
Dividend Yield 2.86%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 27.91%
Buyback Yield n/a
Shareholder Yield 2.86%
Earnings Yield 10.25%
FCF Yield 5.24%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date Apr 14, 2010
Split Type Forward
Split Ratio 2

Scores

Whan In Pharm has an Altman Z-Score of 4.68 and a Piotroski F-Score of 5.

Altman Z-Score 4.68
Piotroski F-Score 5